Literature DB >> 26203154

VPS35 in Dopamine Neurons Is Required for Endosome-to-Golgi Retrieval of Lamp2a, a Receptor of Chaperone-Mediated Autophagy That Is Critical for α-Synuclein Degradation and Prevention of Pathogenesis of Parkinson's Disease.

Fu-Lei Tang1, Joanna R Erion2, Yun Tian3, Wei Liu4, Dong-Min Yin2, Jian Ye5, Baisha Tang6, Lin Mei1, Wen-Cheng Xiong7.   

Abstract

Vacuolar protein sorting-35 (VPS35) is essential for endosome-to-Golgi retrieval of membrane proteins. Mutations in the VPS35 gene have been identified in patients with autosomal dominant PD. However, it remains poorly understood if and how VPS35 deficiency or mutation contributes to PD pathogenesis. Here we provide evidence that links VPS35 deficiency to PD-like neuropathology. VPS35 was expressed in mouse dopamine (DA) neurons in substantia nigra pars compacta (SNpc) and STR (striatum)--regions that are PD vulnerable. VPS35-deficient mice exhibited PD-relevant deficits including accumulation of α-synuclein in SNpc-DA neurons, loss of DA transmitter and DA neurons in SNpc and STR, and impairment of locomotor behavior. Further mechanical studies showed that VPS35-deficient DA neurons or DA neurons expressing PD-linked VPS35 mutant (D620N) had impaired endosome-to-Golgi retrieval of lysosome-associated membrane glycoprotein 2a (Lamp2a) and accelerated Lamp2a degradation. Expression of Lamp2a in VPS35-deficient DA neurons reduced α-synuclein, supporting the view for Lamp2a as a receptor of chaperone-mediated autophagy to be critical for α-synuclein degradation. These results suggest that VPS35 deficiency or mutation promotes PD pathogenesis and reveals a crucial pathway, VPS35-Lamp2a-α-synuclein, to prevent PD pathogenesis. Significance statement: VPS35 is a key component of the retromer complex that is essential for endosome-to-Golgi retrieval of membrane proteins. Mutations in the VPS35 gene have been identified in patients with PD. However, if and how VPS35 deficiency or mutation contributes to PD pathogenesis remains unclear. We demonstrated that VPS35 deficiency or mutation (D620N) in mice leads to α-synuclein accumulation and aggregation in the substantia nigra, accompanied with DA neurodegeneration. VPS35-deficient DA neurons exhibit impaired endosome-to-Golgi retrieval of Lamp2a, which may contribute to the reduced α-synuclein degradation through chaperone-mediated autophagy. These results suggest that VPS35 deficiency or mutation promotes PD pathogenesis, and reveals a crucial pathway, VPS35-Lamp2a-α-synuclein, to prevent PD pathogenesis.
Copyright © 2015 the authors 0270-6474/15/3510614-16$15.00/0.

Entities:  

Keywords:  LAMP2a; Parkinson's disease; VPS35; autophagy; α-synuclein

Mesh:

Substances:

Year:  2015        PMID: 26203154      PMCID: PMC4510296          DOI: 10.1523/JNEUROSCI.0042-15.2015

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  53 in total

Review 1.  Retromer.

Authors:  Juan S Bonifacino; James H Hurley
Journal:  Curr Opin Cell Biol       Date:  2008-05-09       Impact factor: 8.382

Review 2.  Diagnosis and treatment of Parkinson disease: molecules to medicine.

Authors:  Joseph M Savitt; Valina L Dawson; Ted M Dawson
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

3.  Phosphatidylinositol transfer protein-alpha in netrin-1-induced PLC signalling and neurite outgrowth.

Authors:  Yi Xie; Yu-Qiang Ding; Yan Hong; Zhu Feng; Sammy Navarre; Cai-Xia Xi; Xiao-Juan Zhu; Chun-Lei Wang; S L Ackerman; David Kozlowski; Lin Mei; Wen-Cheng Xiong
Journal:  Nat Cell Biol       Date:  2005-11       Impact factor: 28.824

4.  Lysosomal-associated membrane protein 2 isoforms are differentially affected in early Parkinson's disease.

Authors:  Karen E Murphy; Amanda M Gysbers; Sarah K Abbott; Adena S Spiro; Akiko Furuta; Antony Cooper; Brett Garner; Tomohiro Kabuta; Glenda M Halliday
Journal:  Mov Disord       Date:  2015-01-16       Impact factor: 10.338

5.  Retrieval of the Alzheimer's amyloid precursor protein from the endosome to the TGN is S655 phosphorylation state-dependent and retromer-mediated.

Authors:  Sandra I Vieira; Sandra Rebelo; Hermann Esselmann; Jens Wiltfang; James Lah; Rachel Lane; Scott A Small; Sam Gandy; Edgar F da Cruz E Silva; Odete Ab da Cruz E Silva
Journal:  Mol Neurodegener       Date:  2010-10-11       Impact factor: 14.195

6.  Retromer terminates the generation of cAMP by internalized PTH receptors.

Authors:  Timothy N Feinstein; Vanessa L Wehbi; Juan A Ardura; David S Wheeler; Sebastien Ferrandon; Thomas J Gardella; Jean-Pierre Vilardaga
Journal:  Nat Chem Biol       Date:  2011-03-27       Impact factor: 15.040

7.  VPS35 dysfunction impairs lysosomal degradation of α-synuclein and exacerbates neurotoxicity in a Drosophila model of Parkinson's disease.

Authors:  Emiko Miura; Takafumi Hasegawa; Masatoshi Konno; Mari Suzuki; Naoto Sugeno; Nobuhiro Fujikake; Sven Geisler; Mitsuaki Tabuchi; Ryuji Oshima; Akio Kikuchi; Toru Baba; Keiji Wada; Yoshitaka Nagai; Atsushi Takeda; Masashi Aoki
Journal:  Neurobiol Dis       Date:  2014-08-06       Impact factor: 5.996

8.  Comparison of transduction efficiency of recombinant AAV serotypes 1, 2, 5, and 8 in the rat nigrostriatal system.

Authors:  Nikolaus R McFarland; Jeng-Shin Lee; Bradley T Hyman; Pamela J McLean
Journal:  J Neurochem       Date:  2009-02-24       Impact factor: 5.372

9.  SNX27 mediates retromer tubule entry and endosome-to-plasma membrane trafficking of signalling receptors.

Authors:  Paul Temkin; Ben Lauffer; Stefanie Jäger; Peter Cimermancic; Nevan J Krogan; Mark von Zastrow
Journal:  Nat Cell Biol       Date:  2011-05-22       Impact factor: 28.824

10.  Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity.

Authors:  Liyan Qiao; Shusei Hamamichi; Kim A Caldwell; Guy A Caldwell; Talene A Yacoubian; Scott Wilson; Zuo-Lei Xie; Lisa D Speake; Rachael Parks; Donna Crabtree; Qiuli Liang; Stephen Crimmins; Lonnie Schneider; Yasuo Uchiyama; Takeshi Iwatsubo; Yi Zhou; Lisheng Peng; YouMing Lu; David G Standaert; Ken C Walls; John J Shacka; Kevin A Roth; Jianhua Zhang
Journal:  Mol Brain       Date:  2008-11-21       Impact factor: 4.041

View more
  95 in total

1.  Increased Microglial Activity, Impaired Adult Hippocampal Neurogenesis, and Depressive-like Behavior in Microglial VPS35-Depleted Mice.

Authors:  Joanna Ruth Appel; Shiyang Ye; Fulei Tang; Dong Sun; Hongsheng Zhang; Lin Mei; Wen-Cheng Xiong
Journal:  J Neurosci       Date:  2018-05-31       Impact factor: 6.167

2.  Selective imaging of internalized proteopathic α-synuclein seeds in primary neurons reveals mechanistic insight into transmission of synucleinopathies.

Authors:  Richard J Karpowicz; Conor M Haney; Tiberiu S Mihaila; Raizel M Sandler; E James Petersson; Virginia M-Y Lee
Journal:  J Biol Chem       Date:  2017-06-13       Impact factor: 5.157

Review 3.  Deregulation of autophagy and vesicle trafficking in Parkinson's disease.

Authors:  Patricia Sheehan; Zhenyu Yue
Journal:  Neurosci Lett       Date:  2018-04-05       Impact factor: 3.046

Review 4.  The coming of age of chaperone-mediated autophagy.

Authors:  Susmita Kaushik; Ana Maria Cuervo
Journal:  Nat Rev Mol Cell Biol       Date:  2018-06       Impact factor: 94.444

5.  A conserved retromer sorting motif is essential for mitochondrial DLP1 recycling by VPS35 in Parkinson's disease model.

Authors:  Wenzhang Wang; Xiaopin Ma; Leping Zhou; Jun Liu; Xiongwei Zhu
Journal:  Hum Mol Genet       Date:  2017-02-15       Impact factor: 6.150

Review 6.  Defects in trafficking bridge Parkinson's disease pathology and genetics.

Authors:  Asa Abeliovich; Aaron D Gitler
Journal:  Nature       Date:  2016-11-10       Impact factor: 49.962

Review 7.  Mitochondrial dysfunction in protein conformational disorders.

Authors:  Shlomi Brielle; Daniel Kaganovich
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

Review 8.  Autophagy in Parkinson's Disease.

Authors:  Xu Hou; Jens O Watzlawik; Fabienne C Fiesel; Wolfdieter Springer
Journal:  J Mol Biol       Date:  2020-02-13       Impact factor: 5.469

Review 9.  Dysregulation of the autophagic-lysosomal pathway in Gaucher and Parkinson's disease.

Authors:  Caleb Pitcairn; Willayat Yousuf Wani; Joseph R Mazzulli
Journal:  Neurobiol Dis       Date:  2018-03-14       Impact factor: 5.996

Review 10.  Endosomal sorting pathways in the pathogenesis of Parkinson's disease.

Authors:  Lindsey A Cunningham; Darren J Moore
Journal:  Prog Brain Res       Date:  2020-03-16       Impact factor: 2.453

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.